Search Results - Porter, J.B.
- Showing 1 - 3 results of 3
-
1
Insights into relationships between serum ferritin and liver iron concentration trends during 12 months of iron chelation therapy with deferasirox - a post-hoc analysis from the ep... by Porter, J.B., Elalfy, M., Taher, A.T., Chan, L.L., Lee, S.H., Sutcharitchan, P., Aydinok, Y., Chakravarty, S., El-Ali, A., El-Beshlawy, A.
Published 2014Get full text
Article -
2
Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years by Pennell, D., Porter, J.B., Cappellini, M.D., Chan, L.L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, Chi-Kong, Viprakasit, V., Elalfy, M.S., Kattamis, A., Smith, G., Habr, D., Domokos, G., Roubert, B., Taher, A.
Published 2010Get full text
Article -
3
Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia by Pennell, D.J., Porter, J.B., Cappellini, M.D., El-Beshlawy, A., Chan, L.L., Aydinok, Y., Elalfy, M.S., Sutcharitchan, P., Li, C.K., Ibrahim, H., Viprakasit, V., Kattamis, A., Smith, G., Habr, D., Domokos, G., Roubert, B., Taher, A.
Published 2010Get full text
Article
